Butyrate protects against disruption of the blood‐milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide
British Journal of Pharmacology2017Vol. 174(21), pp. 3811–3822
Citations Over TimeTop 10% of 2017 papers
Abstract
In our model, SB protected against LPS-induced mastitis by preserving blood-milk barrier function and depressing pro-inflammatory responses, suggesting the potential use of SB as a prophylactic agent to protect blood-milk barrier function in mastitis.
Related Papers
- → MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease(2017)63 cited
- → Interleukin‐18 disrupts tight junctions in gastric and intestinal epithelial monolayers(2010)1 cited
- → Betaine attenuates LPS-induced downregulation of Occludin and Claudin-1 and restores intestinal barrier function(2019)6 cited
- Intrinsic Differences Of Epithelial Tight Junctions In Asthmatic Airway Epithelium And Barrier Compromisation Following Human Rhinoviral Insult(2015)
- → Progress of tight junction associated protein occludin(2012)